The myc oncogene: MarvelouslY complex

SK Oster, CSW Ho, EL Soucie, LZ Penn - 2002 - Elsevier
The activated product of the myc oncogene deregulates both cell growth and death check
points and, in a permissive environment, rapidly accelerates the affected clone through the …

Cell cycle deregulation in B-cell lymphomas

M Sánchez-Beato… - Blood, The Journal of …, 2003 - ashpublications.org
Disruption of the physiologic balance between cell proliferation and death is a universal
feature of all cancers. In general terms, human B-cell lymphomas can be subdivided into 2 …

miR-21 microRNA expression in human gastric carcinomas and its clinical association

SH Chan, CW Wu, AFY Li, CW Chi, WC Lin - Anticancer research, 2008 - ar.iiarjournals.org
Background: MicroRNAs (miRNAs) are a class of endogenous small non-coding RNAs that
have been shown to be aberrantly expressed in many human carcinomas. Of these miRNAs …

MDM2 and prognosis

K Onel, C Cordon-Cardo - Molecular Cancer Research, 2004 - AACR
The cellular stress response pathway regulated by the p53 tumor suppressor is critical to the
maintenance of genomic integrity and to the prevention of oncogenic transformation …

Expression of microRNAs in diffuse large B cell lymphoma is associated with immunophenotype, survival and transformation from follicular lymphoma

CH Lawrie, J Chi, S Taylor, D Tramonti… - Journal of cellular …, 2009 - Wiley Online Library
MicroRNAs are naturally occurring small RNA species that regulate gene expression and
are frequently abnormally expressed in cancers. However, the role of microRNAs in …

Proteomic analysis of mantle-cell lymphoma by protein microarray

IM Ghobrial, DJ McCormick, SH Kaufmann… - Blood, 2005 - ashpublications.org
Mantle-cell lymphoma (MCL) is a unique subtype of B-cell non-Hodgkin lymphoma (NHL)
that behaves aggressively and remains incurable. In order to understand the pathogenesis …

[HTML][HTML] Mdm2 haplo‐insufficiency profoundly inhibits Myc‐induced lymphomagenesis

JR Alt, TC Greiner, JL Cleveland, CM Eischen - The EMBO journal, 2003 - embopress.org
Mdm2 harnesses the p53 tumor suppressor, yet loss of one Mdm2 allele in Mdm2+/− mice
has heretofore not been shown to impair tumor development. Here we report that Mdm2 …

Variability in immunophenotype in diffuse large B‐cell lymphoma and its clinical relevance

L De Leval, NL Harris - Histopathology, 2003 - Wiley Online Library
Diffuse large B‐cell lymphoma (DLBCL), the single largest category of lymphoma, is a
clinically and biologically heterogeneous disease entity. Clinically, patients differ in their …

Perspectives on c-Myc, Cyclin D1, and their interaction in cancer formation, progression, and response to chemotherapy

DJ Liao, A Thakur, J Wu, H Biliran… - Critical Reviews™ in …, 2007 - dl.begellhouse.com
ABSTRACT C-myc is an oncogene that functions both in the stimulation of cell proliferation
and in and apoptosis. C-myc elicits its oncogenic activity by causing immortalization, and to …

Combined c‐Myc and caveolin‐1 expression in human prostate carcinoma predicts prostate carcinoma progression

G Yang, TL Timme, A Frolov… - … Journal of the …, 2005 - Wiley Online Library
BACKGROUND Over‐expression of the oncogene c‐Myc has been implicated in the
development and progression of human prostate carcinoma. However, previous …